IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Albemarle earnings fall YOY, but beat estimates

4:06 PM MST | January 28, 2014 | Vincent Valk

Albemarle today reported fourth-quarter adjusted earnings of $88.4 million, or $1.08/share, down 16% year-on-year (YOY), but ahead of analysts' consensus estimate of $1.04/share as reported by Thomson Reuters (New York). Adjusted earnings excluded a large pension benefit – including this benefit, earnings totaled $155.9 million, or $1.91/share. Net sales were up 0.6%, to $692 million, on higher volumes in polymers and catalysts. Catalysts segment sales were up 4% YOY, to $306.2 million, while segment income rose 2%, to $80.1 million. Strong volumes in...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa